Adsorption of drugs on nanodiamond: toward development of a drug delivery platform.
Nanodiamond particles produced by detonation synthesis and having ∼5 nm diameter possess unique properties, including low cell toxicity, biocompatibility, stable structure, and highly tailorable surface chemistry, which render them an attractive material for developing drug delivery systems. Although the potential for nanodiamonds in delivery and sustained release of anticancer drugs has been recently demonstrated, very little is known about the details of adsorption/desorption equilibria of these and other drugs on/from nanodiamonds with different purity, surface chemistry, and agglomeration state. Since adsorption is the basic mechanism most commonly used for the loading of drugs onto nanodiamond, the fundamental studies into the details of adsorption and desorption on nanodiamond are critically important for the rational design of the nanodiamond drug delivery systems capable of targeted delivery and triggered release, while minimizing potential leaks of dangerous drugs. In this paper we report on a physical-chemical study of the adsorption of doxorubicin and polymyxin B on nanodiamonds, analyzing the role of purification and surface chemistry of the adsorbent.
A. J. Drexel Nanotechnology Institute and Department of Materials Science and Engineering, Drexel University , Philadelphia, Pennsylvania 19104, United States.
Vadym N
VN
Mochalin
Amanda
A
Pentecost
Xue-Mei
XM
Li
Ioannis
I
Neitzel
Matthew
M
Nelson
Chongyang
C
Wei
Tao
T
He
Fang
F
Guo
Yury
Y
Gogotsi
D000327:Adsorption; D000900:Anti-Bacterial Agents / Q000737:chemistry; D004317:Doxorubicin / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D058612:Nanodiamonds / Q000737:chemistry*; D011112:Polymyxin B / Q000737:chemistry
D000900:Anti-Bacterial Agents; D058612:Nanodiamonds; D004317:Doxorubicin; D011112:Polymyxin B